Allergan plc announced that it has filed with the U.S. FDA the de novo application for the Oculeve Intranasal Tear...
Read moreMerck, a leading science and technology company announced that the EMA to request the company for marketing approval for its...
Read moreThe Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira®1, has been accepted for review by the...
Read moreAdvanced Clinical has been recognized as a Silver Award recipient of PRO Unlimited’s Annual Global Supplier Awards. Recipients of this...
Read more3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform ...
Read moreCepheid announced that its Xpert® HIV-1 Qual test has been awarded WHO prequalification, making it one of the first molecular...
Read moreShire plc announced it has agreed to license global rights to all indications for PF-00547659 from Pfizer Inc. ...
Read moreAmgen announced that the Arthritis Advisory Committee of the U.S. FDA will review data supporting the Company's Biologics License Application...
Read moreEisai Co Ltd. announced that interim analyses on the latest data for the world's first anti-fractalkine monoclonal antibody E6011, discovered...
Read moreMerck in partnership with Pfizer Inc. announced that two Phase 3 studies (VERTIS Mono and VERTIS Factorial) of ertugliflozin, an...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.